Technical Analysis for RUBY - Rubius Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
7.6 | 3.26% | 0.24 |
RUBY closed up 3.26 percent on Monday, November 18, 2019, on 1.15 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| See historical RUBY trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New Downtrend | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 3.26% | |
| New 52 Week Closing Low | Bearish | 3.26% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/14/2019
- Sector: Healthcare
- Industry: Biotechnology
Rubius Therapeutics Inc is a biotechnology company that develops cellular therapies for cancer, and enzyme deficiency diseases. The Company develops Red-Cell Therapeutics (RCT) products using red platform. RCT is a red blood cell-based therapy for applications in cancer, enzyme replacement therapies, and autoimmune disease and tolerance induction. Its RCT product candidate is designed to provide various attributes, which include broad therapeutic applications, predictable bio-distribution and advantageous tolerability. It is initially focused on advancing RCT product candidates for patients suffering from rare diseases, cancer and autoimmune diseases based on three modalities - cellular shielding, potent cell-cell interaction and tolerance induction. Its product candidates in rare diseases include RTX-134 for the treatment of phenylketonuria (PKU), RTX-134 followed by RTX-Uricase and RTX-CBS for the treatment of chronic refractory gout symptomatic homocystinuria.
Biotechnology Cancer Immunology Autoimmune Diseases Rare Diseases Application Software Autoimmunity Autoimmune Disease Therapies For Cancer Computer Aided Engineering Phenylketonuria Enzyme Replacement Therapies Therapeutic Applications
Biotechnology Cancer Immunology Autoimmune Diseases Rare Diseases Application Software Autoimmunity Autoimmune Disease Therapies For Cancer Computer Aided Engineering Phenylketonuria Enzyme Replacement Therapies Therapeutic Applications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more RUBY news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 23.98 |
| 52 Week Low | 6.96 |
| Average Volume | 318,112 |
| 200-Day Moving Average | 13.3514 |
| 50-Day Moving Average | 9.1373 |
| 20-Day Moving Average | 9.4305 |
| 10-Day Moving Average | 9.592 |
| Average True Range | 0.9719 |
| ADX | 25.14 |
| +DI | 11.4525 |
| -DI | 26.5709 |
| Chandelier Exit (Long, 3 ATRs ) | 8.2843 |
| Chandelier Exit (Short, 3 ATRs ) | 9.8757 |
| Upper Bollinger Band | 11.4002 |
| Lower Bollinger Band | 7.4608 |
| Percent B (%b) | 0.04 |
| BandWidth | 41.772971 |
| MACD Line | -0.1759 |
| MACD Signal Line | 0.1183 |
| MACD Histogram | -0.2942 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.43 | ||||
| Resistance 3 (R3) | 8.39 | 8.09 | 8.29 | ||
| Resistance 2 (R2) | 8.09 | 7.88 | 8.10 | 8.24 | |
| Resistance 1 (R1) | 7.84 | 7.75 | 7.97 | 7.88 | 8.20 |
| Pivot Point | 7.54 | 7.54 | 7.60 | 7.55 | 7.54 |
| Support 1 (S1) | 7.29 | 7.33 | 7.42 | 7.33 | 7.00 |
| Support 2 (S2) | 6.99 | 7.20 | 7.00 | 6.96 | |
| Support 3 (S3) | 6.74 | 6.99 | 6.91 | ||
| Support 4 (S4) | 6.78 |
